Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

262 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis.
Aletaha D, Smolen J. Aletaha D, et al. Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S100-8. Clin Exp Rheumatol. 2005. PMID: 16273793 Review.
Advances in anti-inflammatory therapy.
Aletaha D, Smolen JS. Aletaha D, et al. Acta Med Austriaca. 2002;29(1):1-6. doi: 10.1046/j.1563-2571.2002.01037.x. Acta Med Austriaca. 2002. PMID: 11899747 Review.
Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysis.
Aletaha D, Smolen JS. Aletaha D, et al. Arthritis Rheum. 2002 Apr 15;47(2):181-8. doi: 10.1002/art.10266. Arthritis Rheum. 2002. PMID: 11954012
Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.
Aletaha D, Eberl G, Nell VP, Machold KP, Smolen JS. Aletaha D, et al. Ann Rheum Dis. 2002 Jul;61(7):630-4. doi: 10.1136/ard.61.7.630. Ann Rheum Dis. 2002. PMID: 12079906 Free PMC article.
Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study.
Aletaha D, Smolen JS. Aletaha D, et al. J Rheumatol. 2002 Aug;29(8):1631-8. J Rheumatol. 2002. PMID: 12180721
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
Aletaha D, Smolen JS. Aletaha D, et al. Rheumatology (Oxford). 2002 Dec;41(12):1367-74. doi: 10.1093/rheumatology/41.12.1367. Rheumatology (Oxford). 2002. PMID: 12468815
Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis.
Aletaha D, Kapral T, Smolen JS. Aletaha D, et al. Ann Rheum Dis. 2003 May;62(5):482-6. doi: 10.1136/ard.62.5.482. Ann Rheum Dis. 2003. PMID: 12695166 Free PMC article.
The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical care.
Smolen JS, Aletaha D. Smolen JS, et al. Among authors: aletaha d. Curr Rheumatol Rep. 2003 Oct;5(5):336-40. doi: 10.1007/s11926-003-0014-8. Curr Rheumatol Rep. 2003. PMID: 12967513 No abstract available.
Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study.
Aletaha D, Stamm T, Kapral T, Eberl G, Grisar J, Machold KP, Smolen JS. Aletaha D, et al. Ann Rheum Dis. 2003 Oct;62(10):944-51. doi: 10.1136/ard.62.10.944. Ann Rheum Dis. 2003. PMID: 12972472 Free PMC article.
Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeutics.
Aletaha D, Smolen JS. Aletaha D, et al. Curr Rheumatol Rep. 2003 Dec;5(6):409-12. doi: 10.1007/s11926-003-0048-y. Curr Rheumatol Rep. 2003. PMID: 14609484 Review. No abstract available.
262 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback